Gufic Biosciences Clears Rs 4.33 Crore Tax Demand

• Rs 4.33 crore tax demand deleted.
• Appellate authority ruled in favor of Gufic Biosciences.

Reader Takeaway: The company resolves a Rs 4.33 crore liability, strengthening its fiscal position for the 2024-25 assessment year.

What just happened

Gufic Biosciences has received a favorable order from the Commissioner of Income Tax (Appeals) regarding a long-standing tax dispute. The order, dated September 28, 2026, and received on September 29, 2026, pertains to the Assessment Year 2024-25. The appellate authority has ruled to delete an income tax demand of Rs 4,33,36,680, which had previously been raised due to the disallowance of certain expenditures under Section 143 of the Income Tax Act, 1961.

Why this matters

The resolution of this tax demand is a positive development for Gufic Biosciences as it removes a financial liability from its books. By overturning the disallowance of expenditure, the company essentially secures its previously contested financial position for the 2024-25 period. Shareholders should view this as a reduction in potential cash outflow, strengthening the company's net working capital and overall financial health.

What changes now

With this order, the tax demand is effectively nullified. The company no longer faces the immediate obligation to pay the Rs 4.33 crore amount. This resolution allows management to move forward without the overhang of this specific legal and financial uncertainty for the current assessment cycle.

What to track next

Investors should monitor the company's upcoming quarterly filings to observe the formal accounting of this tax reversal and any impact it may have on the company's profit and loss statements.